Bioadhesive compositions for epithelial drug delivery
Disclosed are compositions and methods for treating a disease, such as infection, pain, or inflammation, by using the compositions. Particularly, disclosed is a method of treating oral pain, wherein, the above-described compositions are applied to the oral mucosa; the compositions undergo in-situ gelation, optimal adhesion to the oral mucosa, controlled erosion and controlled release of the active ingredient, i.e., benzocaine, which provides a superior degree of pain relief or analgesia for an extended period of time.
1. A method of delivering a topical anesthetic to a subject in need thereof, comprising administering at room temperature a liquid pharmaceutical composition comprising said topical anesthetic to a tissue of said subject, and maintaining said pharmaceutical composition in contact with said tissue of said subject for a time sufficient for the composition to reach body temperature and transition to a gel, wherein said pharmaceutical composition comprises
a) from about 30 to about 70 weight parts of water;
b) from about 10 to about 30 weight parts of polyethylene glycol (PEG) and/or from about 1 to about 10 weights parts of ethyl alcohol;
c) from about 15 to about 25 weight parts of a copolymer having the following block structure:
HO—[CH2-CH2-O] a -[CH2-CH(CH3)-O] b -[CH2-CH2-O] a -H
wherein the ratio of a:b is from about 1:1 to about 3:1, and the molecular weight of said copolymer is from about 9000 to about 16000; and
d) from about 0.1 to about 3.0 weight parts of xanthan gum,
wherein, said composition turns from a liquid to a gel composition at a temperature between room temperature and the body temperature of said subject; has a capacity to adhere to said tissue when applied to said tissue; and has a capacity to bioerode and elute said active ingredient.
2. The method of delivering a pharmaceutical composition according to claim 1 , wherein, said tissue is a surgical incision or a wound, further comprising closing said surgical incision or wound.
3. The method of delivering a pharmaceutical composition according to claim 1 , wherein, said tissue is oral mucosa.
4. The method of claim 1 , wherein weight parts of said water is from about 40 to about 60.
5. The method of claim 1 , wherein weight parts of said polyethylene glycol is from about 15 to about 25, and/or weight parts of said ethyl alcohol is from about 4 to about 6.
6. The method of claim 1 , wherein weight parts of said copolymer is from about 15 to about 20.
7. The method of claim 1 , wherein weight parts of said xanthan gum is from about 0.1 to about 2.0.
8. The method of claim 1 , wherein said topical anesthetic comprises benzocaine.
9. The method of claim 1 , wherein said copolymer is a poloxamer.
10. The method of claim 1 , wherein said copolymer is poloxamer 407.
11. The method of claim 1 , wherein said polyethylene glycol is PEG 200.
12. The method of claim 1 , wherein said composition comprises:
a) from about 40 to about 45 weight parts of water;
b) from about 15 to about 25 weight parts of polyethylene glycol, and/or from about 3 to about 6 weights parts of ethyl alcohol;
c) from about 15 to about 20 weight parts of poloxamer 407;
d) from about 1.5 to about 2.5 weight parts of xanthan gum; and
e) about 20 weight parts of benzocaine.
13. The method of claim 1 , wherein said composition comprises:
a) about 41.5 weight parts of water;
b) about 20 weight parts of polyethylene glycol, and/or about 4 weights parts of ethyl alcohol;
c) about 16.5 weight parts of poloxamer 407;
d) about 2.0 weight parts of xanthan gum; and
e) about 20 weight parts of benzocaine.
14. The method of claim 1 , wherein said composition comprises:
a) about 43.5 weight parts of water;
b) about 20 weight parts of polyethylene glycol, and/or about 4 weights parts of ethyl alcohol;
c) about 15 weight parts of poloxamer 407;
d) about 1.5 weight parts of xanthan gum; and
e) about 20 weight parts of benzocaine.
15. The method of claim 1 , wherein said active ingredient is released from said composition in zero order rate.
16. The method of claim 1 , wherein said tissue comprises an open wound.
17. The method of claim 1 , wherein the composition has a T sol-gel of from room temperature to 98.6 F.
18. The method of claim 1 , wherein the composition increases in viscosity between room temperature and 98.6 F.